US3441741077
US3441741077
Foghorn Therapeutics Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 70/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±94.1% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 3.0x as much as the broader market.
Beta (Market Relation)
3.01x
Above averageVolatility (5Y p.a.)
94.1% p.a.
5-Year HorizonMax Drawdown (5Y)
-91.4%
5-Year HorizonSharpe Ratio
-0.36
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -55.8% |
| 3 Years | 94.8% | -80.3% | -0.2 | -16.8% |
| 5 Years | 94.1% | -91.4% | -0.36 | -31.5% |
| 10 Years | — | — | — | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
High market risk: Beta of 3.01 indicates above-average volatility compared to the broader market.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (94.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -91.4% in the extended horizon.